MCM8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.552800E-01
Normal-vs-Stage2
7.418000E-01
Normal-vs-Stage3
3.226000E-01
Normal-vs-Stage4
8.135400E-01
Stage1-vs-Stage2
6.995800E-01
Stage1-vs-Stage3
8.948400E-02
Stage1-vs-Stage4
6.317000E-01
Stage2-vs-Stage3
9.185800E-02
Stage2-vs-Stage4
4.864400E-01
Stage3-vs-Stage4
1.755370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.615200E-01
Normal-vs-AfricanAmerican
6.505200E-01
Normal-vs-Asian
6.158400E-01
Caucasian-vs-AfricanAmerican
3.048800E-01
Caucasian-vs-Asian
1.579800E-01
AfricanAmerican-vs-Asian
9.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.607400E-01
Normal-vs-Female
8.966400E-01
Male-vs-Female
5.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.508800E-01
Normal-vs-Age(41-60Yrs)
5.839800E-01
Normal-vs-Age(61-80Yrs)
9.321400E-01
Normal-vs-Age(81-100Yrs)
9.069200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.246800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.723800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.880600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.175700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.063600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.737400E-01
Normal-vs-Daily Drinker
6.800600E-01
Normal-vs-Weekly Drinker
7.681400E-01
Normal-vs-Occasional Drinker
4.221200E-01
Normal-vs-Social Drinker
6.157200E-01
Non Drinker-vs-Daily Drinker
3.466800E-01
Non Drinker-vs-Weekly Drinker
5.504400E-01
Non Drinker-vs-Occasional Drinker
9.947800E-02
Non Drinker-vs-Social Drinker
3.031200E-01
Daily Drinker-vs-Weekly Drinker
2.965000E-01
Daily Drinker-vs-Occasional Drinker
1.276230E-02
Daily Drinker-vs-Social Drinker
7.005800E-02
Weekly Drinker-vs-Occasional Drinker
7.642000E-01
Weekly Drinker-vs-Social Drinker
9.849800E-01
Occasional Drinker-vs-Social Drinker
6.604600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.745000E-01
Normal-vs-Grade 2
7.198400E-01
Normal-vs-Grade 3
7.658000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.581500E-02
Grade 1-vs-Grade 3
8.116400E-03
Grade 1-vs-Grade 4
6.745000E-01
Grade 2-vs-Grade 3
7.810300E-02
Grade 2-vs-Grade 4
7.198400E-01
Grade 3-vs-Grade 4
7.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.027000E-01
Normal-vs-NonDiabetic
8.226000E-01
Diabetic-vs-NonDiabetic
2.016200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.322400E-01
Normal-vs-NoPancreatitis
8.319600E-01
Pancreatitis-vs-NoPancreatitis
2.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.719000E-01
Normal-vs-N1
7.548600E-01
N0-vs-N1
1.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.230400E-01
Normal-vs-TP53-NonMutant
7.120200E-01
TP53-Mutant-vs-TP53-NonMutant
8.261700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
